We are live on ! Find out more
MLNT

Melinta Therapeutics, Inc. Common Stock
MLNT

Delisted

MLNT was delisted on the 10th of January, 2020.

Back to rankings

78 hedge funds and large institutions have $183M invested in Melinta Therapeutics, Inc. Common Stock in 2017 Q4 according to their latest regulatory filings, with 78 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

35% less call options, than puts

Call options by funds: $1.85M | Put options by funds: $2.84M

Holders
78
Holders Change
+78
Holders Change %
–
% of All Funds
1.77%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
78
Increased
–
Reduced
–
Closed
–
Calls
$1.85M
Puts
$2.84M
Net Calls
-$985K
Net Calls Change
-$985K

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$14.6M
2
BlackRock
BlackRock
New York
+$8.95M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$7.73M
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$6.37M
5
Millennium Management
Millennium Management
New York
+$4.13M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
OH
1
Oikos Holdings
New York
$106M +$99.6M +1,345,892 New
Fidelity Investments
2
Fidelity Investments
Massachusetts
$15.6M +$14.6M +197,902 New
BlackRock
3
BlackRock
New York
$9.55M +$8.95M +120,891 New
Vanguard Group
4
Vanguard Group
Pennsylvania
$8.25M +$7.73M +104,415 New
Dimensional Fund Advisors
5
Dimensional Fund Advisors
Texas
$6.8M +$6.37M +86,086 New
Millennium Management
6
Millennium Management
New York
$4.41M +$4.13M +55,783 New
SFM
7
Sphera Funds Management
Israel
$3.16M +$2.96M +40,000 New
NI
8
Numeric Investors
Massachusetts
$2.96M +$2.77M +37,460 New
State Street
9
State Street
Massachusetts
$2.55M +$2.39M +32,297 New
SDIC
10
South Dakota Investment Council
South Dakota
$2.05M +$1.92M +25,988 New
Northern Trust
11
Northern Trust
Illinois
$1.77M +$1.66M +22,445 New
Deutsche Bank
12
Deutsche Bank
Germany
$1.46M +$1.37M +18,550 New
Renaissance Technologies
13
Renaissance Technologies
New York
$1.3M +$1.22M +16,464 New
Geode Capital Management
14
Geode Capital Management
Massachusetts
$1.27M +$1.19M +16,112 New
BCM
15
Bridgeway Capital Management
Texas
$1.24M +$1.16M +15,628 New
TCIM
16
TIAA CREF Investment Management
New York
$1.22M +$1.14M +15,402 New
PAM
17
Panagora Asset Management
Massachusetts
$1.07M +$1.01M +13,602 New
ARTA
18
A.R.T. Advisors
New York
$934K +$876K +11,833 New
PAI
19
Palo Alto Investors
California
$801K +$750K +10,138 New
Charles Schwab
20
Charles Schwab
California
$753K +$705K +9,524 New
Morgan Stanley
21
Morgan Stanley
New York
$675K +$632K +8,544 New
Bank of America
22
Bank of America
North Carolina
$614K +$575K +7,767 New
GF
23
Gabelli Funds
New York
$607K +$568K +7,680 New
Bank of New York Mellon
24
Bank of New York Mellon
New York
$592K +$554K +7,483 New
Susquehanna International Group
25
Susquehanna International Group
Pennsylvania
$536K +$502K +6,784 New
1
2 3 4

MLNT Hedge Fund Activity: Q4 2017 in Review

78 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Melinta Therapeutics, Inc. Common Stock (MLNT) for Q4 2017, worth a combined $183M.

Buyers outnumbered sellers: 78 funds opened new MLNT positions and 0 closed out — a net gain of 78 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $14.6M.

  • 78 institutional investors held Melinta Therapeutics, Inc. Common Stock (MLNT) as of Q4 2017, up from 0 in Q3 2017.
  • Funds reported $183M of Melinta Therapeutics, Inc. Common Stock stock for Q4 2017.
  • 78 funds opened new Melinta Therapeutics, Inc. Common Stock positions in Q4 2017 and 0 closed out, a net change of +78 holders.
  • The largest Melinta Therapeutics, Inc. Common Stock buyer in Q4 2017 was Fidelity Investments, an estimated $14.6M added.

Based on aggregated 13F filings for Q4 2017.